North America Pharmaceutical Glass Vials And Ampoules Market

North America Pharmaceutical Glass Vials And Ampoules Market Analysis

The North America Pharmaceutical Glass Vials And Ampoules Market size is worth USD 1.39 Billion in 2025, growing at an 5.42% CAGR and is forecast to hit USD 1.81 Billion by 2030.

• The pharmaceutical industry is one of the most innovative industries in the region, with a robust development and manufacturing facility for generic drugs. Furthermore, the introduction of stringent laws to enhance the quality and integrity of domestically manufactured drugs in the region is leading to an increase in the use of glass for pharmaceutical packaging products.
• A rise in the usage of glass for pharmaceutical vials and ampoules is attributed to the advent of strict legislation designed to improve the integrity and quality of pharmaceuticals produced domestically. The pharmaceutical industry’s growing need for sterile medical packaging products is anticipated to fuel the market's expansion throughout the forecast period.
• Glass remains a preferred material for pharmaceutical packaging due to its chemical durability and compatibility with various chemical compositions. Glass vials and ampoules offer enhanced transparency, facilitating easy viewing and monitoring of contents. Additionally, glass provides superior protection as it is chemically resistant to most pharmaceuticals and relatively impermeable to air and moisture.
• Furthermore, the increasing demand for sterile medical packaging products from pharmaceutical industries would further drive the growth of the studied market during the forecast period.
• The rising demand for injectable pharmaceuticals significantly boosts the growth of glass vials and ampoules. The robust demand for oncology and other high-potency drugs, such as antibody conjugates, steroids, and IV fluids requiring rapid onset of action, is expected to be a key growth driver.
• The pharmaceutical industry is heavily regulated, with stringent requirements for packaging materials to ensure safety and efficacy. Compliance with these regulations can be time-consuming and costly for manufacturers, potentially limiting the market’s growth.

North America Pharmaceutical Glass Vials And Ampoules Market Trends

Ampoules to Hold Significant Market Share

• Ampoules are commonly used for vaccines, biologics, and injectable medications. The increasing demand for vaccines, coupled with the rising prevalence of chronic diseases, contributes to the growth of the pharmaceutical packaging industry. As a result, the market for glass ampoules is expected to witness a substantial increase.
• The surge in demand for vaccine packaging solutions is aided by consumers' high number of vaccines, and the major vaccination drives are organized by mainstream organizations like WHO and UNICEF. This has led to a significant increase in demand for glass ampoules in end-use sectors such as hospitals, diagnostic centers, research programs, and other healthcare units.
• Stringent regulatory requirements for pharmaceutical packaging, especially for vaccines, often favor using glass due to its chemical inertness and the ability to withstand sterilization processes. This compliance drives the demand for glass ampoules in pharmaceutical packaging. Ensuring an adequate supply of pharmaceutical glass ampoules for the vaccine distribution is crucial for a response's success.
• Governments and pharmaceutical companies in the region are placing hundreds of millions of orders and urging primary packaging glass manufacturers to increase their production capacity.
• The International Trade Centre states that the United States of America accounts for 2.6% of global exports of glass ampoules (HS Code - 701010). In 2023, United States total exports reached USD 4,830 thousand. Of this total, USD 2064 thousand were shipped to Japan, making it one of the primary destinations. Additionally, USD 1,232 thousand were exported to Mexico.
• With such a significant portion of exports going to key markets, there may be increased interest from investors and stakeholders in the ampoules packaging sector. This can lead to the developing of new facilities, advanced manufacturing processes, and research into new packaging solutions within North America.

United States to Hold Significant Market Share

• The United States is one of the major packaging markets globally, and many vital players produce glass vials and ampoules for pharmaceuticals. As the economy continuously grows, increasing consumer spending on healthcare and medicines drives the demand for glass packaging solutions.
• Companies that comply with FDA regulations are better positioned to market their products, which increases demand for packaging solutions that meet these standards. Pharmaceutical glass vials and ampoules that adhere to FDA regulations for safety features, such as child resistance and tamper evidence, are expected to witness higher demand.
• According to The Pharmaceutical Research and Manufacturers of America, in 2023, its member companies' research and development (R&D) expenditure reached USD 71.34 billion compared with 2019, which was USD 64.35 billion.
• As pharmaceutical companies invest more in R&D, they may develop new formulations and delivery methods that require specialized vials. For instance, biologics and complex vaccines often require specific types of vials, such as those made from materials that can preserve sensitive components.
• Higher health expenditure typically correlates with increased pharmaceutical investment, including new drugs and biologics. This will drive the demand for pharmaceutical glass vials and ampoules to store and deliver these products.
• According to the Centers for Medicare & Medicaid Services, the total health expenditure of the United States is forecasted to reach USD 6.93 trillion in 2030, compared with USD 4.8 trillion in 2023.
• With greater spending, healthcare services and facilities, including hospitals, clinics, and vaccination centers, are expected to expand. This expansion will lead to a higher need for pharmaceutical packaging to manage and distribute medications and vaccines, including glass vials and ampoules.

North America Pharmaceutical Glass Vials And Ampoules Industry Overview

The North America pharmaceutical glass vials and ampoules market is fragmented, with major players like Schott Pharma (Schott AG), Gerresheimer AG, Berlin Packaging, and Pacific Vial Manufacturing Inc. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

North America Pharmaceutical Glass Vials And Ampoules Market Leaders

North America Pharmaceutical Glass Vials And Ampoules Market News

• March 2024: SCHOTT Pharma, a player in pharmaceutical drug containment solutions and delivery systems, planned to construct the first United States facility for manufacturing prefillable polymer syringes. The project will involve a total investment of USD 371 million and create 401 new jobs in the region. Groundbreaking is expected by the end of 2024, with operations projected to commence in 2027. The company may also consider manufacturing vials and ampoules in the future.
• January 2024: SCHOTT Pharma developed glass vials specifically designed for deep-cold storage of medications. These vials are crucial for preserving life-saving vaccines, including gene therapy and mRNA treatments, which require freezing and transportation at temperatures as low as -80°C. Traditional vials are susceptible to breakage due to the extreme thermal stress and other factors involved in the freezing and thawing. This breakage often leads to significant drug loss and costly production delays.
• October 2023: Gerresheimer, a global partner for the pharmaceutical and biotechnology industries, launched Cyclic Olefin Polymer (COP) vials. These vials offer an effective solution for filling and storing highly sensitive biologics. The COP vials are suitable for mRNA active ingredients at temperatures as low as -80°C and can withstand cryogenic conditions.